About MetaResearch

MetaResearch writes about research itself. We read studies on blood sugar and weight, on aging and longevity, and on new kinds of medicine. For each study, we report three things. What did the scientists really measure? How much can the result be trusted? And what is still unknown?

Every article starts from the first and fullest record. That means the published paper, the trial's entry in a public list of studies, or the official drug label. It does not start from a news story or a press release. Numbers are given just as the scientists reported them. Each source has a number in the text, so readers can find it. When two studies disagree, we show both results. Some findings come from animals. Some come from a small group of patients. Some come from looking back at the data after a study ended. When that is true, the article says so right next to the number.

MetaResearch is published by MRG Canada. It reports on research only. It gives no medical advice. It does not recommend or supply anything. It has no doctors' office or clinic behind it. Anyone with a health question is told to ask their own doctor or nurse. MRG Canada also owns a laboratory supply business. That business is the partner whose offer is in one of our emails. It has no say in what we write.

What we write about

• Metabolic. Studies about blood sugar, body weight, and the hormones that make people feel hungry or full. Also the medicines made to work on them. (A hormone is a chemical messenger the body makes.)
• Longevity. Studies about how the body gets older. Also the tests that try to measure that, and how much those tests can be trusted.
• Advanced Biologics. Medicines made from living things and built in a lab. This includes antibodies, which are proteins that grab onto germs or other targets. It includes fusion proteins, which are two proteins joined into one. And it includes enzymes, which are proteins that speed up a job in the body. We cover how they are made, how they are tested, and what tests in people show so far.
• Trials explained. How studies in people, called clinical trials, are planned, counted and written up. Also what makes a result well proven, and what makes one still early.

Who has a say

MetaResearch is editorially independent. That means no partner and no ad buyer has a say in what it writes. It is not part of, or connected to, Meta Platforms, Inc., the company that runs Facebook and Instagram.

MetaResearch is paid for by an offer from a partner in one of our emails. The partner is a laboratory supply business. It is owned by MRG Canada, the same company that publishes MetaResearch. The email names the partner and labels the offer. There are no ads on the site right now. If ads are added, they will be labeled where they appear. The partner and any ad buyer have no say in which studies we cover. They have no say in what an article concludes, or in how a finding is described. No one outside the editors sees an article before it is published. Sometimes an offer is about a subject MetaResearch also writes about. Then the article is still written from the first and fullest sources. It says exactly what it would have said with no offer attached.